Approvals/TGA/FLUTICASONE SALMETEROL CIPHALER 500/50 fluticasone propionate 500 microgram / salmeterol (as xinfoate) 50 microgram powder for inhalation blister pack

Approved

STANDARD

FLUTICASONE SALMETEROL CIPHALER 500/50 fluticasone propionate 500 microgram / salmeterol (as xinfoate) 50 microgram powder for inhalation blister pack

Cipla Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: May 30, 2025
Approval ID: 2f70aa0df4bae76f
Company: Cipla Australia Pty Ltd
Type: Standard

Approval Details

Approval Id: 2f70aa0df4bae76f
Product Name: FLUTICASONE SALMETEROL CIPHALER 500/50 fluticasone propionate 500 microgram / salmeterol (as xinfoate) 50 microgram powder for inhalation blister pack
Artg Id: 371362
Artg Name: FLUTICASONE SALMETEROL CIPHALER 500/50 fluticasone propionate 500 microgram / salmeterol (as xinfoate) 50 microgram powder for inhalation blister pack
Sponsor: Cipla Australia Pty Ltd
Company Detail Path: /organization/cipla-australia-pty-ltd
Artg Date: 2022-09-29
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/3d08aa3742d7a363221ed46b50075523.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/b5510e39dd06710ef97a1623b02e1012.pdf

Active Ingredients

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

2f70aa0df4bae76f

Type

Standard

Back to TGA Approvals